FTC launches probe into pharmacy benefit management sector

FTC launches probe into pharmacy benefit management sector

Source: 
Pharmaforum
snippet: 

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being formally investigated by the Federal Trade Commission (FTC).